AIDS News and Research

RSS

AIDS activists and advocates to protest against Gilead's drug pricing at San Francisco federal building

A small group of committed AIDS activists and advocates spearheaded by AIDS Healthcare Foundation (AHF) will protest the Bay Area's own Gilead Sciences over its pricing and policies on its HIV/AIDS medications.

13 Jul 2011

IAS, NIDA announce recipients of third annual joint research fellowships

The International AIDS Society (IAS) and the US National Institute on Drug Abuse (NIDA) today announced the recipients of their third annual joint research fellowships. Recipients of the prestigious awards will receive US$75,000 each to advance scientific understanding of the linkages between drug use and HIV while fostering multinational research.

13 Jul 2011

NIH grants $70M over five years to help search for HIV cure

NIH announced on Monday it will provide $70 million over five years to three collaborations searching for an HIV/AIDS cure, making it "the largest single investment yet … into finding a way to rid the virus from the body or at least reduce levels to the point that infected people can stop taking anti-HIV drugs - which many researchers until recently viewed as a hopeless quest," ScienceInsider reports.

13 Jul 2011

AHF applauds Gilead for licensing AIDS drugs to Medicines Patent Pool

AIDS Healthcare Foundation (AHF) today lauded Gilead Sciences for being the first major AIDS drug company to share some drug patents with a new international Medicines Patent Pool, a move that will help ensure access to newer AIDS treatments in developing countries.

13 Jul 2011

Gilead becomes first company to license drugs to Medicines Patent Pool

"In the first agreement between a pharmaceutical company and the new international Medicines Patent Pool, Gilead Sciences announced Tuesday that it would license four of its AIDS and hepatitis B drugs to the pool," the New York Times reports.

13 Jul 2011

Donors should continue to provide AIDS funding to China, UNAIDS head says

Cutting AIDS funding to China will "be a big mistake for a donor and particularly, for anyone who's invested in China today, ... for the simple reason that this funding is a catalytic fund," UNAIDS Executive Director Michel Sidibe told Reuters in an interview on Monday.

13 Jul 2011

Sexually transmitted diseases more common in women age 40

A Johns Hopkins infectious disease expert is calling for all sexually active American women age 40 and older to get tested for the parasite Trichomonas vaginalis after new study evidence found that the sexually transmitted disease (STD) is more than twice as common in this age group than previously thought.

12 Jul 2011

Gilead, Mylan expand license deal for HIV/AIDS medicines

Mylan Inc. today announced an expanded licensing agreement between Gilead Sciences Inc. and Mylan's Matrix Laboratories Limited.

12 Jul 2011

UNC receives $32 million federal grant to eradicate HIV infection

Researchers at the University of North Carolina at Chapel Hill have been awarded a $32 million, five-year federal grant to develop ways to cure people with HIV by purging the virus hiding in the immune systems of patients taking antiretroviral therapy.

12 Jul 2011

New research strategy for eradicating HIV from the body

An international team led by researchers from the University of California, San Francisco and the nonprofit Vaccine and Gene Therapy Institute of Port St. Lucie, Fla., has received a major grant from the National Institutes of Health to develop a strategy to eradicate HIV from the body.

12 Jul 2011

Merck researchers to participate in two new collaborative efforts to study HIV latency

Merck, known as MSD outside the United States and Canada, today announced that company researchers will participate in two new collaborative efforts led by the prominent academic institutions of the University of North Carolina (UNC) Chapel Hill and the University of California San Francisco (UCSF) to develop new approaches towards eradicating HIV, the virus that causes AIDS.

12 Jul 2011

Gilead announces expansion of global access program for HIV medications

Gilead Sciences, Inc. announced today an expansion of its global access program in an effort to provide accelerated access to Gilead medicines for the treatment of HIV/AIDS.

12 Jul 2011

Scientists to receive prestigious awards for innovative HIV research at IAS 2011

The International AIDS Society (IAS) announced today the six winners of three prestigious scientific awards, to be presented at plenary sessions during the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention to be held in Rome July 17-20, 2011.

12 Jul 2011

Federal funds may help Gladstone to solve problem of HIV latency

The Gladstone Institutes will receive funds totaling $5.6 million over five years as part of the first-ever major funding initiative focusing on HIV eradication.

12 Jul 2011

NIAID awards $14 million a year for new HIV research

Three research teams focused on developing strategies that could help to rid the body of HIV are receiving grants totaling more than $14 million a year, for up to five years, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health announced today.

11 Jul 2011

Nurses can help manage S. African's syndemic of TB and HIV

Jason E. Farley, PhD, MPH, CRNP knows the dangers inherent to an increasingly common and hazardous syndemic in South Africa: HIV and drug-resistant tuberculosis.

11 Jul 2011

New tool reveals mutations that cause HIV-drug resistance

Protease inhibitor drugs are one of the major weapons in the fight against HIV, the virus that causes AIDS, but their effectiveness is limited as the virus mutates and develops resistance to the drugs over time.

11 Jul 2011

AIDS Healthcare Foundation rolls out new national ad campaign

As part of its ongoing advocacy efforts to spur President Obama and his administration to do more on AIDS, AIDS Healthcare Foundation is rolling out a new national ad campaign headlined 'What has the President done about AIDS?' The first leg of the campaign, a series of pointed online text and banner ads on Politico.com's Playbook and Pulse websites started running Monday July 4th on Mike Allen's Politico Playbook and will run through Friday July 15th on Politico's Pulse.

11 Jul 2011

Federal appeals court rules government cannot force health groups to take anti-prostitution pledge

"A federal appeals court has ruled that the United States cannot force partners in its international fight against AIDS to denounce prostitution as a condition for receiving funding," the Associated Press reports. Three health organizations sued the government in 2005, saying some groups "advocate for a reduction in penalties for prostitution to prevent interference with outreach efforts," according to the news agency (7/6).

8 Jul 2011

Next phase of HIV programming must focus on sustainable health systems response

"Now, we are in the Third-Generation of AIDS programming, in which the focus must be on a sustainable, health systems response, especially in the countries most affected by HIV & AIDS," Jonathan Quick, president and CEO of Management Sciences for Health, writes on the organization's "Global Health Impact" blog.

8 Jul 2011